ACCEPT SIMS AI™ · BloomShield CIC

BloomShield-branded research demonstrator

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
4,024
Screening encounters
4,762
Diagnostic referrals
908
Outstanding pathways
324

Screening pathway

  1. Screening4,762Encounters
  2. Positive finding1,642Documented findings
  3. Referral908Diagnostic referrals
  4. Follow-up1,085Diagnostic visits
  5. Outcome584Resolved pathways

Stage totals use different units. Pending pathways: 324. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 2159 · EXP-2159Synthetic · Site C

Full participant history through 2026-12-22, across modalities and pathways.

  1. · Screening · VIA · Initial · Programme entry
  2. · Screening result · VIA · VIA positive · Adequate
  3. · Repeat plan · HPV DNA · Prior VIA positive · Scheduled for 2027-01-11
  4. · Diagnostic referral · EXP-2159-T-R
  5. · Barrier documented · Transport difficulty
  6. · Contact attempt · Reached
  7. · Diagnostic booking · Initial booking
  8. · Barrier documented · Contact difficulty
  9. · Diagnostic visit · Attended
  10. · Diagnosis · Colposcopy · Biopsy collected
  11. · Diagnosis · Histopathology · No high-grade lesion identified
  12. · Surveillance plan · HPV DNA · After clinical assessment · Scheduled for 2027-09-22
  13. · Follow-up disposition · Resolved · EXP-2159-T-R

Referral-time risk

Pathway status at observation · Resolved

Loading prediction…

Observed day-60 outcome · Resolved

Screened participants

4024 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-2898 · Expanded synthetic participant 2898Site C — Rural Outreach Programme
EXP-2899 · Expanded synthetic participant 2899Site D — Community Engagement Programme
EXP-2900 · Expanded synthetic participant 2900Site D — Community Engagement Programme
EXP-2901 · Expanded synthetic participant 2901Site A — Urban Referral Hub
EXP-2902 · Expanded synthetic participant 2902Site A — Urban Referral Hub
EXP-2903 · Expanded synthetic participant 2903Site E — Resource-Constrained Navigation Programme
EXP-2904 · Expanded synthetic participant 2904Site A — Urban Referral Hub
EXP-2907 · Expanded synthetic participant 2907Site B — Peri-Urban Access Programme
EXP-2909 · Expanded synthetic participant 2909Site D — Community Engagement Programme
EXP-2911 · Expanded synthetic participant 2911Site E — Resource-Constrained Navigation Programme
EXP-2912 · Expanded synthetic participant 2912Site D — Community Engagement Programme
EXP-2913 · Expanded synthetic participant 2913Site B — Peri-Urban Access Programme
EXP-2914 · Expanded synthetic participant 2914Site A — Urban Referral Hub
EXP-2915 · Expanded synthetic participant 2915Site C — Rural Outreach Programme
EXP-2916 · Expanded synthetic participant 2916Site C — Rural Outreach Programme
EXP-2918 · Expanded synthetic participant 2918Site A — Urban Referral Hub
EXP-2919 · Expanded synthetic participant 2919Site A — Urban Referral Hub
EXP-2920 · Expanded synthetic participant 2920Site B — Peri-Urban Access Programme
EXP-2921 · Expanded synthetic participant 2921Site D — Community Engagement Programme
EXP-2922 · Expanded synthetic participant 2922Site C — Rural Outreach Programme
EXP-2923 · Expanded synthetic participant 2923Site A — Urban Referral Hub
EXP-2924 · Expanded synthetic participant 2924Site D — Community Engagement Programme
EXP-2925 · Expanded synthetic participant 2925Site A — Urban Referral Hub
EXP-2926 · Expanded synthetic participant 2926Site C — Rural Outreach Programme
EXP-2928 · Expanded synthetic participant 2928Site B — Peri-Urban Access Programme

Programme insights

Encounters by modality

VIA
1813
HPV DNA
2278
Cytology
671

Navigation activity

Barrier documented
812
Contact attempt
1334
Navigation intervention
351
Diagnostic booking
1134
Diagnostic visit
1085

Documented barriers

Contact difficulty
259
Transport difficulty
267
Appointment coordination
286

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.